Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion type Assertion NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_head.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion description "[Immunohistochemical analysis on a tissue microarray consisting of 91 human prostate specimens, including normal, prostatic hyperplasia, high-grade prostatic intraepithelial neoplasia, and invasive carcinoma, revealed that overexpression of LMO2 was significantly associated with advanced tumour stage, as measured by Gleason score (p = 0.012), as well as with the development of distant metastasis (p = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_provenance.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion evidence source_evidence_literature NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_provenance.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion SIO_000772 17167821 NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_provenance.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion wasDerivedFrom befree-20140225 NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_provenance.
- NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_assertion wasGeneratedBy ECO_0000203 NP892059.RAncXzg0UIpt0M-fp6R5UAy1ZQjtbq0KEvb8cMwaPPPUU130_provenance.